Ray Boyapati

2.4k total citations
37 papers, 942 citations indexed

About

Ray Boyapati is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Ray Boyapati has authored 37 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 12 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Ray Boyapati's work include Inflammatory Bowel Disease (17 papers), Microscopic Colitis (10 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Ray Boyapati is often cited by papers focused on Inflammatory Bowel Disease (17 papers), Microscopic Colitis (10 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Ray Boyapati collaborates with scholars based in Australia, United Kingdom and United States. Ray Boyapati's co-authors include Gwo‐Tzer Ho, Jack Satsangi, Adriano G. Rossi, Nicholas A. Kennedy, Jack Satsangi, Joana Torres, Jean‐Frédéric Colombel, Édouard Louis, Rahul Kalla and Nicholas T. Ventham and has published in prestigious journals such as Gastroenterology, Cochrane Database of Systematic Reviews and The American Journal of Gastroenterology.

In The Last Decade

Ray Boyapati

31 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ray Boyapati Australia 12 410 303 286 282 233 37 942
Rahul Kalla United Kingdom 15 493 1.2× 279 0.9× 221 0.8× 542 1.9× 281 1.2× 52 1.1k
Amosy E. M’Koma United States 19 521 1.3× 356 1.2× 266 0.9× 260 0.9× 157 0.7× 43 1.0k
Ágota Kovács Hungary 17 631 1.5× 491 1.6× 260 0.9× 140 0.5× 231 1.0× 43 1.0k
Roni Weisshof United States 14 551 1.3× 376 1.2× 192 0.7× 116 0.4× 148 0.6× 30 794
Tomer Adar Israel 19 221 0.5× 345 1.1× 302 1.1× 140 0.5× 131 0.6× 57 976
Olof Grip Sweden 18 381 0.9× 310 1.0× 237 0.8× 221 0.8× 447 1.9× 28 1.1k
Trevor A. Winter South Africa 17 509 1.2× 454 1.5× 344 1.2× 131 0.5× 128 0.5× 39 1.0k
María Asunción García-González Spain 20 222 0.5× 158 0.5× 450 1.6× 264 0.9× 387 1.7× 60 1.3k
Abdul Elkadri United States 11 536 1.3× 216 0.7× 238 0.8× 186 0.7× 396 1.7× 20 886
Masamichi Satomi Japan 14 648 1.6× 456 1.5× 314 1.1× 184 0.7× 329 1.4× 31 1.1k

Countries citing papers authored by Ray Boyapati

Since Specialization
Citations

This map shows the geographic impact of Ray Boyapati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ray Boyapati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ray Boyapati more than expected).

Fields of papers citing papers by Ray Boyapati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ray Boyapati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ray Boyapati. The network helps show where Ray Boyapati may publish in the future.

Co-authorship network of co-authors of Ray Boyapati

This figure shows the co-authorship network connecting the top 25 collaborators of Ray Boyapati. A scholar is included among the top collaborators of Ray Boyapati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ray Boyapati. Ray Boyapati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goodsall, Thomas M, Claire E. Parker, Alice S. Day, et al.. (2025). Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows? Authors' Reply. Alimentary Pharmacology & Therapeutics. 62(8). 855–856.
2.
Goodsall, Thomas M, Claire E. Parker, Alice S. Day, et al.. (2025). Expert Position Statement: Defining the Role of Intestinal Ultrasound in Assessing Constipation and Faecal Loading. Alimentary Pharmacology & Therapeutics. 62(8). 799–808. 2 indexed citations
3.
Boyapati, Ray, Karen M. Fischer, Donna K. Lawson, et al.. (2025). Innovative telehospitalist model optimizes medical triage in collaboration with community emergency departments: A cross-sectional study. Journal of Telemedicine and Telecare. 32(1). 32–39.
4.
Boyapati, Ray, et al.. (2025). AML-1421: Clues in the Blood: Uncovering AML in a Patient With Suspected Tick-Borne Infection. Clinical Lymphoma Myeloma & Leukemia. 25. S506–S506.
5.
Taylor, Sarah, Ray Boyapati, Bei Ye, et al.. (2025). Blood Group B May Reduce Risk of Rebleeding in Patients With Upper Gastrointestinal Haemorrhage due to Peptic Ulcer Disease. Alimentary Pharmacology & Therapeutics. 61(4). 706–711. 1 indexed citations
6.
Pagali, Sandeep R., Simon Kung, Ray Boyapati, et al.. (2025). Transcranial Electrical Stimulation in Treatment of Depression. JAMA Network Open. 8(6). e2516459–e2516459. 1 indexed citations
7.
Shelton, Edward, et al.. (2024). Feasibility of transperineal intestinal ultrasound in assessing ulcerative proctitis during pregnancy. JGH Open. 8(11). e70035–e70035. 1 indexed citations
8.
9.
Sinopoulou, Vassiliki, et al.. (2023). Vedolizumab for induction and maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews. 2023(7). CD013611–CD013611. 7 indexed citations
10.
Ho, Gwo‐Tzer, Rhona Aird, Ray Boyapati, et al.. (2017). MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation. Mucosal Immunology. 11(1). 120–130. 88 indexed citations
11.
Kalla, Rahul, Nicholas A. Kennedy, Nicholas T. Ventham, et al.. (2016). Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases. The American Journal of Gastroenterology. 111(12). 1796–1805. 84 indexed citations
12.
Boyapati, Ray, Rahul Kalla, Jack Satsangi, & Gwo‐Tzer Ho. (2016). Biomarkers in Search of Precision Medicine in IBD. The American Journal of Gastroenterology. 111(12). 1682–1690. 40 indexed citations
13.
Kalla, Rahul, Nicholas A. Kennedy, Nicholas T. Ventham, et al.. (2016). PWE-025 Serum Calprotectin – A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases. A150.1–A150. 1 indexed citations
14.
Boyapati, Ray, Adriano G. Rossi, Jack Satsangi, & Gwo‐Tzer Ho. (2016). Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications. Mucosal Immunology. 9(3). 567–582. 120 indexed citations
15.
Torres, Joana, Ray Boyapati, Nicholas A. Kennedy, et al.. (2015). Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease. Gastroenterology. 149(7). 1716–1730. 166 indexed citations
16.
Robertson, Marcus, Avik Majumdar, Ray Boyapati, et al.. (2015). Risk stratification in acute upper GI bleeding: comparison of the AIMS65 score with the Glasgow-Blatchford and Rockall scoring systems. Gastrointestinal Endoscopy. 83(6). 1151–1160. 100 indexed citations
17.
Boyapati, Ray, Jack Satsangi, & Gwo‐Tzer Ho. (2015). Pathogenesis of Crohn's disease. F1000Prime Reports. 7. 44–44. 74 indexed citations
18.
Boyapati, Ray, et al.. (2015). Suspected acute hemolytic transfusion reaction mediated by anti-Di a. Immunohematology. 31(4). 163–165. 1 indexed citations
19.
Boyapati, Ray. (2014). One fifth of hospitalizations for peptic ulcer-related bleeding are potentially preventable. World Journal of Gastroenterology. 20(30). 10504–10504. 5 indexed citations
20.
Boyapati, Ray, et al.. (2013). Acute liver injury secondary to sertraline. BMJ Case Reports. 2013. bcr2013201022–bcr2013201022. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rahul Kalla Breakdown of academic impact, for papers by Amosy E. M’Koma Breakdown of academic impact, for papers by Ágota Kovács Breakdown of academic impact, for papers by Roni Weisshof Breakdown of academic impact, for papers by Tomer Adar Breakdown of academic impact, for papers by Olof Grip Breakdown of academic impact, for papers by Trevor A. Winter Breakdown of academic impact, for papers by María Asunción García-González Breakdown of academic impact, for papers by Abdul Elkadri Breakdown of academic impact, for papers by Masamichi Satomi
Rankless by CCL
2026